ATUM

Trending Articles

  1. Driving sustainable transition in pharmaceutical packaging The pharmaceutical industry, although dedicated to improving human health, is increasingly grappling with the challenge of balancing this mission with environmental...
  2. Blood plasma processing: when every drop counts Plasma derivatives obtained from human blood support the treatment of various diseases — from haemophilia and antigen defects to COVID-19. The products are in high demand and...
  3. Olon continues its growth with a new acquisition The acquisition of Huvepharma Italia Srl increases production capacity and expands market presence
  4. AI in IT/OT integration: how technology can overcome cybersecurity hurdles Manufacturing Chemist (MC) spoke to Rene Hackl (RH), Managing Director at Phytools about how artificial intelligence (AI) can revolutionise IT/OT integration
  5. Have you seen the latest from METTLER TOLEDO on advanced filling solutions? Join METTLER TOLEDO’s free webinar to explore weight-based filling for greater accuracy and control

Upcoming event

Pharmaconex

8-10 September 2024 | Conference | Cairo, Egypt See all

Related Content

Manufacturing

Rentschler and ATUM announce Leap-In Transposase agreement

Rentschler and ATUM have announced the signing of a CDMO licensing agreement for the Leap-In Transposase platform
Research & Development

ATUM licenses gene design software to Thermo Fisher Scientific

Patented Gene Designer 2.0 software speeds discovery with visually rich graphical interface
Research & Development

ATUM launches cell-line development service

Expansion is supported by four broad patents for company’s Leap-In Transposase technology
Research & Development

DNA2.0 Becomes ATUM

Founded in 2003 to marry computational design and gene synthesis, DNA2.0 was a pioneer in the application of machine learning (or artificial intelligence) to biology
Subscribe now